QIAGEN (QGEN)
(Delayed Data from NYSE)
$41.08 USD
-0.44 (-1.06%)
Updated Apr 25, 2024 04:00 PM ET
After-Market: $41.09 +0.01 (0.02%) 5:48 PM ET
4-Sell of 5 4
C Value F Growth D Momentum F VGM
- YR Estimate
- 12/31/2023
- 12/31/2022
- 12/31/2021
- 12/31/2020
- 12/31/2019
- Revenue - Line of Business (LOBR)
- Net Sales: Consumables and related revenues
- 1,726.00
- 1,888.90
- 1,986.30
- 1,615.00
- 1,354.00
- Revenue - Line of Business (LOBR)
- Net Sales: Instruments
- 239.00
- 252.60
- 265.30
- 255.00
- 172.00
- Revenue - Line of Business (LOBR)
- Revenue: Molecular Diagnostics
- 1,035.00
- 1,126.20
- 1,143.66
- 904.00
- 737.00
- Revenue - Line of Business (LOBR)
- Net Sales: Non-Covid product groups
- 1,805.00
- 1,672.00
- 1,547.00
- --
- --
- Revenue - Line of Business (LOBR)
- Net Sales: Covid-19 product groups
- 160.00
- 470.00
- 704.00
- --
- --
- Revenue - Line of Business (LOBR)
- Sales by Product Groups: Sample technologies
- 663.00
- 796.90
- 850.60
- 803.87
- --
- Revenue - Line of Business (LOBR)
- Sales by Product Groups: Diagnostic solutions
- 698.00
- 660.90
- 638.80
- 460.76
- --
- Revenue - Line of Business (LOBR)
- Sales by Product Groups: Diagnostic solutions: QuantiFERON
- 408.00
- 330.00
- 281.00
- --
- --
- Revenue - Line of Business (LOBR)
- Sales by Product Groups: Diagnostic solutions: QIAstat-Dx
- 88.00
- 88.00
- 75.00
- --
- --
- Revenue - Line of Business (LOBR)
- Sales by Product Groups: Diagnostic solutions: NeuMoDx
- 42.00
- 83.00
- 105.00
- --
- --
- Revenue - Line of Business (LOBR)
- Sales by Product Groups: Diagnostic solutions: Other
- 159.00
- 160.00
- 178.00
- --
- --
- Revenue - Line of Business (LOBR)
- Revenue: Life Sciences
- 930.00
- 1,015.30
- 1,107.99
- 966.37
- 789.29
- Revenue - Line of Business (LOBR)
- Sales by Product Groups: Other
- 66.00
- 68.00
- 83.00
- 76.60
- --
- Revenue - Line of Business (LOBR)
- Sales by Product Groups: Genomics / NGS
- 239.00
- 224.80
- 245.10
- 165.57
- --
- Revenue - Line of Business (LOBR)
- Sales by Product Groups: PCR / Nucleic acid amplification
- 300.00
- 390.80
- 434.00
- 363.55
- --
- Revenue - Geographic (GEOR)
- Geographical Revenue: United States
- 1,020.06
- 909.62
- 909.69
- 728.60
- 663.87
- Revenue - Geographic (GEOR)
- Geographical Revenue: Europe, Middle East and Africa
- 624.57
- 733.47
- 814.42
- 682.30
- 487.48
- Revenue - Geographic (GEOR)
- Geographical Revenue: Asia Pacific, Japan and Rest of World
- 320.68
- 410.29
- 429.86
- 362.60
- 316.96